The financials
Acadia Healthcare Company, Inc. by the numbers
Acadia Healthcare Company, Inc. (ACHC) reported revenue of $829M in Q1 2026 (quarter ended March 31, 2026), up 7.6% from the same quarter a year earlier. That came with net income of $4.1M (0.5% of revenue). For the full year FY2025, revenue was $3.31B (+5.0% year on year) and net income −$1.10B. Its largest product in 2026-Q1 was Acute Inpatient Psychiatric Facilities at $471M, 57% of the disclosed total, just ahead of Comprehensive Treatment Centers at 17%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $829M | $771M | +7.6% |
| Operating income | $11M | $13M | −19% |
| Net income | $4.1M | $8.4M | −51% |
| Diluted EPS | $0.05 | $0.09 | −44% |
| Product | Revenue | Share |
|---|---|---|
| Acute Inpatient Psychiatric Facilities | $471M | 57% |
| Comprehensive Treatment Centers | $140M | 17% |
| Specialty Treatment Facilities | $128M | 15% |
| Residential Treatment Centers | $90M | 11% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q1 2026Total $828.8M (-2.7%)
Acute Inpatient Psychiatric Facilities grew +14% year on yearSpecialty Treatment Facilities -6.5% year on year
Segment Latestquarter on quarteryear on year
- Acute Inpatient Psychiatric Facilities$470.7M$470.7MQoQ -0.17%year on year +14%-0.17%+14%
- Comprehensive Treatment Centers$140.4M$140.4MQoQ -2.8%year on year +2.5%-2.8%+2.5%
- Specialty Treatment Facilities$128.1M$128.1MQoQ -14%year on year -6.5%-14%-6.5%
- Residential Treatment Centers$89.6M$89.6MQoQ +2.5%year on year +6.3%+2.5%+6.3%